RNS Number : 7048L
Camellia PLC
06 June 2025
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN (TOGETHER THIS "ANNOUNCEMENT") IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES OF AMERICA, AUSTRALIA, NEW ZEALAND, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, SINGAPORE , SWITZERLAND OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION (EACH BEING A "RESTRICTED JURISDICTION").

 

Camellia plc

 

("Camellia" or the "Company")

 

6 June 2025

 

Result of Tender Offer & Total Voting Rights


Camellia plc (AIM: CAM) is pleased to announce the result of the Tender Offer, details of which were set out in the circular published by the Company on 19 May 2025 (the "Circular").

 

The maximum aggregate number of Ordinary Shares that could be purchased pursuant to the Tender Offer was 350,000 Ordinary Shares, representing 12.8 per cent. of the Company's issued share capital. The Tender Price was £54.00 per Ordinary Share.

 

In total, 215,084 Ordinary Shares were validly tendered, equal to 7.8 per cent. of the shares in issue as at 19 May 2025. As the Tender Offer was not fully subscribed, validly tendered Basic Entitlements and any Individual Excess Tenders will be satisfied in full.

 

Accordingly, a total of 215,084 Ordinary Shares will therefore be purchased under the Tender Offer. The total value which will be returned to Shareholders pursuant to the Tender Offer will be approximately £11,614,536.

 

Payment of the consideration due to Shareholders, whose tenders under the Tender Offer have been accepted, is expected to be paid by no later than 19 June in respect of shares held in CREST and also by no later than 19 June by cheque in respect of shares held in certificated form along with balance certificates in respect of non-tendered shares.

 

 

Total Voting Rights

 

As detailed in the Circular, all Ordinary Shares that were tendered will be cancelled. Following the conclusion of the Tender Offer, the remaining number of Ordinary Shares in issue will be 2,590,295. The Company has 62,500 issued Ordinary Shares which are held by subsidiaries of the Company (the "Subsidiary-Held Ordinary Shares") and under the Companies Act 2006 no voting rights are exercisable in respect of these Subsidiary-Held Ordinary Shares whilst they remain so held. Therefore, the total voting rights in Camellia will be 2,527,795. This figure for the total number of voting rights may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Capitalised terms in this announcement (unless otherwise defined) have the same meanings as set out in the Circular.

 

The person responsible for arranging the release of this announcement on behalf of the Company is Oliver Capon, Chief Financial Officer.

 

Contacts:

 

Camellia plc

Byron Coombs, Chief Executive Officer

Oliver Capon, Chief Financial Officer

 

 

+44 (0) 1622 746 655

 

Panmure Liberum (Nominated Adviser and Broker)

Emma Earl / Will Goode / Rupert Dearden

 

+44 (0) 20 7886 2500

Equitory Limited (Investor Relations)
Catherine Miles

 


H/Advisers Maitland (Financial PR)

William Clutterbuck

+44 (0) 7785 292617



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEKELFBEQLXBBX